The impact of the COVID-19 pandemic on pediatric rheumatology practice: an international, cross-sectional survey study
Authors' conclusion
The findings of our study indicate a significant alteration in pediatric rheumatology practice due to the pandemic. This includes increased caution when prescribing anti-rheumatic drugs, a transition towards telemedicine utilization, delays in routine care, and a rise in COVID-19-related inflammatory conditions.
Study context
- Population
- Pediatric rheumatologists from 70 countries
- Participants
- 469 participants70 countries
- Outcome
- Impact of the COVID-19 pandemic on pediatric rheumatology practice
Methodological detailsinternational, online survey, 22-question online survey by the EMERGE group of Pediatric Rheumatology European Society (PReS) on SurveyMonkey
- International
- Online survey
- 22-question online survey by the EMERGE group of PReS on SurveyMonkey
Main finding
As reported in the abstract
- Drug prescription practice not affected by the pandemic
- 65.3 %
- Prescribing biologic drugs less often
- 24.3 %
- Prescribing corticosteroids less often
- 16.5 %
- Increased number of patients with vasculitis or chilblains during the pandemic
- Over 40 %
- No adjustments in clinical practice after 2.5 years of pandemic
- One-third
- Telemedicine ≥10 % of clinical practice
- one-third
- Still delays in patient care due to the pandemic
- 35.5 %
- Practice returning to pre-pandemic routine
- ∼90 %
Observational data: associations, not effects.
Original publication
The impact of the COVID-19 pandemic on pediatric rheumatology practice: an international, cross-sectional survey study. Semin Arthritis Rheum. Published 29 October 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →